Edition:
United Kingdom

BB Biotech AG (BION.S)

BION.S on Swiss Exchange

66.85CHF
23 May 2018
Change (% chg)

CHF-0.20 (-0.30%)
Prev Close
CHF67.05
Open
CHF67.00
Day's High
CHF67.00
Day's Low
CHF66.25
Volume
71,814
Avg. Vol
109,896
52-wk High
CHF74.00
52-wk Low
CHF54.20

Latest Key Developments (Source: Significant Developments)

BB Biotech Q1 Profit Of CHF 28 Mln
Friday, 20 Apr 2018 

April 20 (Reuters) - BB Biotech AG ::DGAP-ADHOC: BB BIOTECH SHARE GAINS VALUE IN FIRST QUARTER 2018 - SEVERAL LARGE-CAP BIOTECH COMPANIES TRADING AT WELL BELOW FUNDAMENTAL VALUE.Q1 PROFIT OF CHF 28 MN (CHF 375 MN IN CORRESPONDING PERIOD OF PREVIOUS YEAR).  Full Article

BB Biotech Q3 net profit down at CHF 365 million
Friday, 20 Oct 2017 

Oct 20 (Reuters) - BB BIOTECH AG ::PRODUCT APPROVALS AND SOLID COMPANY RESULTS LEAD THE BIOTECH SECTOR HIGHER.Q3 ‍NET PROFIT AMOUNTED TO CHF 365 MN VERSUS PROFIT OF CHF 392 MN REPORTED IN Q3 LAST YEAR​.  Full Article

BB Biotech swings to prelim Q3 profit of CHF 392.1 mln
Tuesday, 11 Oct 2016 

BB Biotech AG : BB Biotech AG with profit in the third quarter 2016 . Based on preliminary unaudited consolidated results, BB Biotech closed Q3 of 2016 with a profit of 392.1 million Swiss francs ($401.41 million)(575.4 million francs loss in corresponding period of previous year) .For nine months period ended September 30, 2016 BB Biotech reports a loss of 777.8 million Swiss francs (141.4 million francs profit in corresponding period of previous year).  Full Article

BB Biotech reports 5.1 pct passive stake in Esperion Therapeutics
Tuesday, 27 Sep 2016 

Esperion Therapeutics Inc :BB Biotech AG reports 5.1 pct passive stake in Esperion Therapeutics as of September 22, 2016 - SEC filing.  Full Article

BB Biotech Q2 net profit of CHF 36 mln
Friday, 22 Jul 2016 

BB Biotech AG : Expects a return to growth from its portfolio holdings in coming quarters and for FY 2016 as a whole . Q2 net profit of 36 million Swiss francs ($36.59 million) .Net result for first half was a negative 1170 million Swiss francs due to loss reported for Q1.  Full Article

BB Biotech swings to H1 net loss of CHF 1.17 bln
Monday, 11 Jul 2016 

BB Biotech AG :Based on preliminary unaudited consolidated results, BB Biotech AG closed first half year of 2016 with a loss of 1.17 billion Swiss francs ($1.19 billion)(717 million Swiss francs profit in corresponding period of previous year)..  Full Article

Swiss stocks - Factors to watch on April 20

ZURICH, April 20The Swiss blue-chip SMI was seen opening with little change 8,838 points on Friday, according to premarket indications by bank Julius Baer .